Medical therapy

Original Contribution

Percutaneous Coronary Intervention Versus Medical Therapy in the Treatment of Stable Coronary Artery Disease: An Updated Meta-Analysis of Contemporary Randomized Controlled Trials

08/01/2021

Jari A. Laukkanen, MD^1,2,3; Setor K. Kunutsor, MD^4,5; Carl J. Lavie, MD⁶

Jari A. Laukkanen, MD1,2,3; Setor K....

The net clinical benefit of percutaneous coronary intervention (PCI) compared with medical therapy (MT) alone for the treatment of stable coronary artery disease (CAD) remains uncertain. We conducted an updated meta-analysis of randomized...

The net clinical benefit of...

08/01/2021

Journal of Invasive Cardiology

Original Contribution

Acute Kidney Injury and Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

08/01/2021

Newton Phuong, MD¹; Richard J. Solomon, MD²; Michael J. DeSarno, MS³; Martin M. LeWinter, MD¹; Joshua Zimmer, MD⁴; Harold L. Dauerman, MD¹

Newton Phuong, MD1; Richard J. Solom...

RAS inhibition after TAVR has been associated with lower cardiac mortality and heart failure readmissions. We analyzed 735 consecutive TAVR patients (2014-2019) who survived to hospital discharge at a high-volume TAVR center to determine the...

RAS inhibition after TAVR has...

08/01/2021

Journal of Invasive Cardiology

Race a Factor in Mortality in Heart Attack Patients on Clopidogrel

07/07/2014

Among patients taking clopidogrel, the one-year mortality rate for African Americans was 7.2 percent, compared with 3.6 percent for Caucasians.

Among patients taking...

07/07/2014

Cath Lab Digest